EXPO Stock Analysis — Exponent Inc.
Sector: Consulting
AI Verdict
EXPO trades at 27.8x next year's earnings for just 5.2% EPS growth, so you're paying a premium the numbers don't yet support unless its reputation-driven moat continues to deliver outsized wins.
Competitive Moat
Exponent specializes in scientific and engineering consulting for complex litigation and regulatory matters, leveraging a deep bench of PhDs and proprietary analytical methods. Its defensibility comes from high client switching costs and a reputation for expertise in highly technical, high-stakes cases.
Summary
EXPO is notable for its niche in technical litigation consulting, where reputation and expertise drive repeat business.
Where It Stands
EXPO returned 4.2% revenue growth last year and trades at 27.8x forward earnings, above the consulting sector’s typical 20x, while its forward EPS growth is just 5.2%.
Key Metrics
- Trailing P/E: 29.3x
- Forward P/E: 27.8x
- PEG Ratio: 5.63
- Earnings Growth: +0.1%
- Revenue Growth: +0.0%
- Dividend Yield: 0.02%
- 52-Week High: $81.95
- 52-Week Low: $63.25
Analyst Consensus
8 Buy · 2 Hold · 0 Sell (10 analysts)
Bull Case
With a forward P/E of 27.8x, investors are paying up for the company’s specialized expertise and consistent demand, even as forward EPS is expected to grow only 5.2%.
Bear Case
If the P/E compresses to the sector median of 20x, the stock could lose nearly 28% from current multiples, especially given the modest 5.2% EPS growth outlook.
Catalyst to Watch
Watch for new high-profile litigation wins or regulatory contracts, as these could justify the premium multiple.